Searched for
GENZYME CORPORATION
Aurobindo Pharma arm gets USFDA nod for Plerixafor injectionAurobindo Pharma said Plerixafor injection is indicated in combination with granulocyte-colony stimulating factor (G-CSF) to mobilise hemat...- Aurobindo Pharma arm gets USFDA nod for Sevelamer hydrochloride tabletsAurobindo Pharma Ltd on Wednesday said its wholly-owned subsidiary APL Healthcare has received a final approval from the US health regulato...
- Elon Musk's acrimonious Twitter bid heads for business school case study immortalisation"This is unique in many cases," said Arturo Bris, Professor of Finance and Director of IMD World Competitiveness Center. "It is definitely ...
- Lupin launches generic medication in US marketLupin has launched Sevelamer Hydrochloride tablets (800 mg), used to treat hyperphosphatemia in patients with chronic kidney disease, in th...
- Lupin gets USFDA nod to market generic Sevelamer Carbonate tabletsThe product is indicated for the control of serum phosphorus in adults and children 6 years of age and older with chronic kidney disease on...
- Glenmark Pharma gets USFDA nod for drug for patients on dialysisThe approved product is a generic version of Genzyme Corporation's Renagel tablets.
- DRL launches anti-cancer drug in US marketAccording to a statement issued by the city-based drug maker, its generic version of the injection is available in single-dose, 20 ml flint...
- Cipla gets USFDA nod for generic version of Renvela tabletsThe approved product is a generic equivalent to the reference listed drug (RLD), Renvela tablets, 800 mg of Genzyme Corporation, said Cipla.
- Indian Institute of Foreign Trade concludes summer placementsAround 80 recruiters made offers to the batch of 282 students. Companies hired students aggressively and 16 companies recruited more than f...
- ETMarkets After Hours: Pharma stocks heal market; FMCG reboundsPharma stocks made impressive gains on Wednesday, led by Aurobindo Pharma.
- Dr Reddy's plunges nearly 2% on patent infringement suitDr Reddy's Laboratories plunged as much as 1.85% in a weak market on Monday after Genzyme Corporation filed a suit against the company.
- Eleven stocks in focus in Monday morning tradeIndian markets are likely to trade in a range. Here is a list of eleven stocks which are likely to be in focus in trade today.
- Genzyme Corporation files patent infringement suit against DRLMozobil (plerixafor injection) is a hematopoietic stem cell mobiliser indicated to patients with non-Hodgkin's lymphoma (blood cancer) and ...
- Glenmark settles patent row with Daiichi, GenzymeGlenmark Pharmaceuticals on Monday said it has settled a patent infringement litigation with Daiichi Sankyo and Genzyme.
- Glenmark settles patent infringement litigation with Daiichi, GenzymeThe company has received a licence from Daiichi Sankyo and Genzyme that will permit it to launch its generic Colesevelam Hydrochloride prod...
- Glenmark settles litigation with Daiichi Sankyo; stock upGlenmark Pharmaceuticals has reached at a settlement agreement with Daiichi Sankyo, Inc and Genzyme Corporation in regards with Glenmark’s ...
- Sanofi extends $18.5 bn bid for Genzyme againIn a statement Sanofi-aventis said its offer of $69 per Genzyme share was extended till February 15 midnight.
- Sanofi extends $18.5bn offer for Genzyme till Jan 21Sanofi-aventis has a significant presence in India. Last year, Sanofi-aventis had sought to acquire an 80pc stake in ShanthaBiotechnics for...
- ‘Innovation can only be funded by branded therapies’In an e-mail interview with ET, Henri A Termeer, Chairman, President & CEO of Genzyme Corporation discusses the latest trends in the area o...
Load More
